News

Yeztugo (lenacapavir) will be the first option that gives people who need or want PrEP the option of injecting only twice a ...
Utah biochemist Wesley Sundquist has achieved yet another milestone with the Food and Drug Administration approval of an ...
A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...
Clinical trials showed 99.9% of participants who received the drug, called Yeztugo​ from company Gilead Sciences, remained ...
The twice-yearly injectable drug’s potential could be compromised by the Trump administration’s dramatic cuts to ...
The Food and Drug Administration has approved a drug that reduces the chances of contracting HIV. A University of Utah ...
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...
June 19, 2025 – The FDA has approved the first twice-yearly shot to reduce the risk of HIV infections.
Embattled CytoDyn and key ex-executives must face an investor lawsuit claiming the company knowingly misled shareholders ...
Yeztugo, a twice-a-year antiviral shot to prevent HIV, was approved by the Food and Drug Administration on Wednesday, marking ...